This is the authors' abstract. We don't add key points for this paper.
Precision oncology seeks to improve cancer care by tailoring treatment to the unique molecular characteristics of each patient's tumor.In the past 30 years, targeted therapies directed against specific molecular driver alterations have revolutionized outcomes in several types of cancer.Early enthusiasm for this approach led to several trials evaluating the clinical utility of more comprehensive genomic profiling (CGP), incorporating testing for mutations in dozens or hundreds of genes at once, to guide therapy selection.
No takes yet. Share an insight, caveat, or question.
Kenneth L. Kehl (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: